MOLBIO DIAGNOSTICS STRENGTHENS LEADERSHIP WITH APPOINTMENT OF TWO DISTINGUISHED PUBLIC HEALTH ADVOCATES
Goa, India – November 26, 2024 – Molbio Diagnostics, a pioneer in global healthcare, is pleased to announce the appointment of Professor (Dr.) Balram Bhargava and Dr. Arun Kumar Jha as Independent Directors to its board.
These strategic appointments reinforce Molbio’s commitment to advancing diagnostics and bridging healthcare gaps globally. Professor (Dr.) Balram Bhargava brings over 35 years of experience in medical research and health system strengthening. His previous roles include Director-General of the Indian Council of Medical Research and Secretary of India’s Department of Health Research.
Dr. Arun Kumar Jha has a wealth of experience in public health and policy, including his role as an Adviser in the Department of Economic Affairs, Ministry of Finance. He is currently working as the Hon’ble Chancellor of the National Institute of Advanced Manufacturing Technology (NIAMT) and Senior Adviser in John Snow India Pvt. Ltd.
“We are honored to welcome Dr. Bhargava and Dr. Jha to our board,” said Mr. Sriram Natarajan, Director and CEO of Molbio Diagnostics. “Their impressive backgrounds and shared dedication to improving healthcare access align perfectly with our vision of transforming global health landscapes.”
Molbio Diagnostics remains dedicated to its mission of enhancing healthcare accessibility through innovative diagnostics solutions. The inclusion of Dr. Jha and Dr. Bhargava on the board is expected to further strengthen the company’s impact on global health.
About Molbio Diagnostics:
Molbio Diagnostics Pvt. Ltd. is a leader in revolutionizing point-of-care diagnostics globally. With a commitment to providing rapid, reliable, and robust diagnostic solutions, Molbio brings advanced healthcare technologies to the last mile.
Loading ...
